MEI Pharma, Kyowa Kirin Enter Global Partnership
April 15, 2020
Late-stage pharmaceutical company based in San Diego, MEI Pharma, and Japanese drug discovery company, Kyowa Kirin, have entered into a global license, development, and commercialization agreement for ME-401.